Anzeige
Mehr »
Login
Dienstag, 10.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die Goldaktie, die sogar KI-Giganten in den Schatten stellt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
199 Leser
Artikel bewerten:
(1)

Frequency Exchange Corp.: Superhuman 2 "Rebirth" Introducing Nikki

VANCOUVER, BC / ACCESSWIRE / August 8, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), is partnering with Caroline Cory, an Award Winning Executive Producer known for her documentaries that air on Netflix and Prime Video. Caroline has millions of viewers and continues to produce films of interest, particularly in the world of frequencies.

In 2020, an unprecedented documentary "Superhuman: the invisible made visible" attempts to quantify the effects of consciousness on the physical body under rigorous scientific conditions and in real time. Being the first documentary production of its kind, the film has gained multiple accolades and film awards across the globe.

Superhuman's award-winning director and producer Caroline Cory, who is herself a pioneer in the field of meditation and consciousness studies, is currently in production on the sequel Superhuman 2: "Rebirth." Caroline has worked with world-renowned scientists and experts from Harvard Medical School, Harvard Smithsonian, IONS and Stanford University conducting scientific experiments on the correlation between consciousness, health and the physical body. She has also developed revolutionary methodologies, all frequency-based, for clearing deep-seated traumas from the subconscious mind and cellular memory with impressive accuracy and speed.

Cory's new film "Superhuman 2: Rebirth" features such icons as Deepak Chopra, Bruce Lipton, Michael Beckwith, Lynn McTaggart, and Dr. Leigh Erin Connealy. In this new production, the team focuses on frequency-based devices and technologies that addresses the body's intelligence to enhance, restore and repair the many imbalances we face today. One of the favorite technologies in the film is "NIKKI", a personal frequency delivery system. This is a brilliantly designed device, it's your own personal frequency delivery system worn on your wrist, that delivers various frequency packages via red light. The packages include frequencies that assist in the battle with Lyme disease, inflammation and pain, heart conditions and general well-being.


"This is such an exciting film filled with great insight on the body's innate ability to heal itself by using frequencies," says Caroline Cory, Executive Producer of Superhuman 2. "My interview with co-inventor of "NIKKI", Stephen Davis sheds some 'light' on howand why their process around capturing and delivering frequencies works. I have witnessed first-hand the many benefits of wearing my NIKKI and will continue to do so. Watch for the new film release later in the year and the revolutionary methodologies and devices featured in the film. To me, 'NIKKI' is the winning technology of the year."
- Caroline Cory

"Thank you, Caroline, to you and your team that did the filming around my small part. The people you have interviewed on this film will shed 'light' in the realms of frequencies and how good cellular communication plays a major role if not the role in living a healthier life. What a privilege to not only be part of Superhuman 2: "Rebirth", but to have 'NIKKI' our personal frequency delivery system, featured in your film, we are honored."
- Stephen Davis, CEO of Frequency Exchange Corp.

About the Company

Based in British Columbia, Canada, Frequency Exchange is focused on the development and global commercialization of "NIKKI" a Personal Frequency Delivery System. NIKKI means "Victor of the People" as it helps all walks of life. FREmedica has created a specialized Lyme support program designed to help people struggling with Lyme disease along with several wellness programs to assist with issues around sleep, pain, energy and immunity to name a few. The categories of frequencies continue to grow. This wearable technology combined with these frequency-based wellness programs is the result of years of development and experimentation with advanced bioenergetic technology.

www.WeAreNikki.com
www.FrequencyExchangeCorp.com

For more information, please contact:

Frequency Exchange Corp. FREmedica Technologies Inc.

Stephen Davis
CEO and Director
250-732-7170

Nicole Sullivan
President
nicole.sullivan@wearenikki.com

Cautionary Note Regarding Forward-Looking Information

Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the trading date of the Company's common shares on the Exchange. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company's profile on SEDAR at www.sedar.com.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Meta Description to add to CMS:

FREmedica founder Stephen Davis interviewed in upcoming documentary Superhuman 2: "Rebirth" along with featuring the company's personal frequency delivery device NIKKI. The film focuses on frequency-based devices and technologies with Caroline Cory and other notable icons in the bioenergetic space.

SOURCE: Frequency Exchange Corp.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Nach der Korrektur – 3 Kupferproduzenten für das Comeback

Kupfer wird oft als „das Gold der Energiewende“ bezeichnet, weil es aufgrund seiner hervorragenden elektrischen Leitfähigkeit eine zentrale Rolle in vielen Technologien spielt, die für nachhaltige Energiesysteme entscheidend sind. Experten gehen aufgrund der Angebotsknappheit von einem Superzyklus aus.

Korrektur als Einstiegschance

Nach Höchstständen im Mai korrigierte das rote Metall stark. Die Abwärtsspirale verstärkte sich in den vergangenen Tagen aufgrund schwacher Konjunkturdaten aus den USA und China. Langfristig könnte sich die aktuell laufende Korrektur als exzellente Einstiegsmöglichkeit herausstellen.

3 Kupferaktien mit hohem Potential

Im neuen, kostenlosen Spezialreport stellen wir drei aussichtsreiche Unternehmen vor, die bei einem weiteren Anstieg überproportional profitieren könnten.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.